Document Detail


Midostaurin (PKC412) modulates differentiation and maturation of human myeloid dendritic cells.
MedLine Citation:
PMID:  20685248     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Midostaurin, a tyrosine kinase inhibitor, has been shown efficacy against acute myeloid leukemia and various other malignancies in clinical trials. Prior studies indicate midostaurin affects the function of immune cells such as lymphocytes and macrophages. To understand the effect of midostaurin on human myeloid dendritic cells (DCs), we conducted an ex vivo study using immature DCs differentiated from CD14(+) monocytes and further maturated using lipopolysaccharide. Addition of midostaurin to a culture of starting CD14(+) monocytes markedly and dose-dependently reduced DC recovery. Mature DCs differentiating in the presence of midostaurin had fewer, shorter cell projections than those differentiating in the absence of midostaurin. Changes in morphological features characteristic of apoptotic cells were also evident. Moreover, midostaurin affected DC differentiation and maturation patterns; CD83 expression levels decreased, whereas CD14 and CD80 expressions increased. Additionally, DCs derived in the presence of midostaurin possessed a lower endocytotic capacity and less allostimulatory activity on naive CD4(+)CD45(+)RA(+) T cell proliferation than those derived in its absence, suggesting that midostaurin redirects DC differentiation toward a less mature stage and that this effect is not solely due to its cytotoxicity. Whether this effect underlies immune suppression or tolerance to disease treatments with unwanted immune reactions needs further evaluation.
Authors:
Yu-Chuen Huang; Hui-Ru Shieh; Yu-Jen Chen
Related Documents :
12914758 - Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proin...
3667468 - Simulated efficiency of range beef production. ii. fertility traits.
15749858 - Exacerbation of granuloma formation in il-1 receptor antagonist-deficient mice with imp...
19628298 - Inhibition of the proteasome influences murine and human dendritic cell development in ...
2825378 - In vitro models of lung toxicity.
12914758 - Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proin...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-26
Journal Detail:
Title:  Toxicology in vitro : an international journal published in association with BIBRA     Volume:  24     ISSN:  1879-3177     ISO Abbreviation:  Toxicol In Vitro     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-31     Completed Date:  2010-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8712158     Medline TA:  Toxicol In Vitro     Country:  England    
Other Details:
Languages:  eng     Pagination:  1705-10     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, CD / metabolism
Antineoplastic Agents / pharmacology*
Apoptosis / drug effects
Biological Markers / metabolism
Bone Marrow Cells / cytology*
Cell Differentiation / drug effects
Cell Proliferation / drug effects
Cells, Cultured
Dendritic Cells / drug effects*,  immunology,  pathology
Endocytosis / drug effects
Humans
Lipopolysaccharides / pharmacology
Protein Kinase C / antagonists & inhibitors*
Staurosporine / analogs & derivatives*,  pharmacology
Transport Vesicles / drug effects
Chemical
Reg. No./Substance:
0/Antigens, CD; 0/Antineoplastic Agents; 0/Biological Markers; 0/Lipopolysaccharides; 120685-11-2/4'-N-benzoylstaurosporine; 62996-74-1/Staurosporine; EC 2.7.11.13/Protein Kinase C

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nitrile hydratases (NHases): at the interface of academia and industry.
Next Document:  Effects of alcohol-drinking behaviour and ADH1B and ALDH2 polymorphisms on basal DNA damage in human...